innovative vaccine platform that helps prevent infections and reduce the global threat of antimicrobial resistance
Vaxdyn has raised €26M across 2 funding rounds from 4 investors, most recently a round in Sep 2026. Based in Seville, Spain; active in Healthtech. Data as of 21 Sept 2026.
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-09-10 | Other | €11M | Arcano Partners,Biovance Capital,EIC Fund | View deal → |
| 2024-09-04 | Other | €15M | EIC Accelerator | View deal → |
